Synergistic FGF21-Inducing Systems for Personalized Nutrition and Health

Publication ID: 24-11857579_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic FGF21-Inducing Systems for Personalized Nutrition and Health,” Published Technical Disclosure No. 24-11857579_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857579_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,579.

Summary of the Inventive Concept

The present inventive concept integrates FGF21-inducing Bifidobacterium strains with cutting-edge technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for personalized nutrition planning, FGF21 level monitoring, and data security.

Background and Problem Solved

The original patent disclosed a composition for promoting the secretion of FGF21, but it had limitations in terms of personalization, data tracking, and security. The new inventive concept addresses these limitations by incorporating synergistic combinations of technologies to provide a more comprehensive and effective solution.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for personalized nutrition planning, which includes a database of user profiles, a database of FGF21-inducing Bifidobacterium strains, and a machine learning module for recommending a personalized FGF21-inducing Bifidobacterium strain to a user based on their profile and health goals. Additionally, the system includes a method for monitoring FGF21 levels in a subject using a wearable IoT device and a cloud-based analytics platform. Furthermore, a blockchain-based system is used to secure and track FGF21-related data, ensuring data integrity and confidentiality. The composition for promoting FGF21 secretion is also enhanced with a graphene-based material for improving the bioavailability of the bacterium. Finally, an AI-powered genomics tool is used to predict FGF21 responsiveness in a subject by analyzing their genetic profile and identifying genetic markers associated with FGF21 responsiveness.

Novelty and Inventive Step

The new claims introduce novel synergistic combinations of FGF21-inducing Bifidobacterium strains with AI, IoT, blockchain, and new materials, which provide a more comprehensive and effective solution for personalized nutrition planning, FGF21 level monitoring, and data security. The inventive step lies in the integration of these distinct technologies to create a more powerful system that overcomes the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms for personalized nutrition planning, the integration of additional IoT devices for more comprehensive health tracking, or the development of new materials for enhancing the bioavailability of the bacterium. Variations of the blockchain-based system could include the use of different consensus algorithms or the integration of additional security protocols.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the personalized nutrition and health industries, with potential applications in areas such as precision medicine, health and wellness, and food technology. The target market includes companies and organizations involved in personalized nutrition, health monitoring, and data security, as well as individuals seeking personalized health solutions.

Original Patent Information

Patent NumberUS 11,857,579
TitleComposition for promoting the secretion of FGF21
Assignee(s)Morinaga Milk Industry Co., Ltd.